A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Phase 1/2
55
about 5 years
18+
Female only
2 sites in NJ, NY
What this study is about
Researchers are testing whether pre-operative mpMRI with additional sequences can improve surgical outcomes by providing more accurate information about the extent and acidity of the tumor than standard MRI. The trial also tests if using the fluorescent imaging agent pHLIP ICG during surgery, along with NIRF imaging, allows surgeons to see cancer cells in the tumor and nearby tissues more clearly and remove them completely.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo pHLIP® ICG NIRF imaging
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Dose-limiting toxicity (DLT)
imaging
diagnostic
Oncology